Pinnacle Health Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2007
NCT00508976
First Marketed Drug
2009
bicalutamide (casodex)
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Pinnacle Health; Community General Osteopathic Hospital | Pinnacle Health System | PINNACLE LIFE SCI

Active Ingredients

Marketed Drugs (1)

bicalutamide (casodex) (2009)

Drugs in Phase 2 Trials (2)

levobupivacaine (chirocaine) (1 trial)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Obesity, Morbid (Phase 2)

Pain, Postoperative (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2